• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Overlays

hate to admit it, this is where biotech is heading following big pharma

BG-12 will be submitted in this first half of this year.
FF will have to expand by around 45; still competing with Novartis' larger sales force
BG-12 will have a dedicated FF in first position; it will not be Ty reps
Smaller footprints? not happening
 




Overlays get bonused on the sum of two territories. While you are sitting around with a poor attitude, bitching about things you can't control, overlays are getting good bonuses. Whether you welcome them into you territory or not.
 




Overlays get bonused on the sum of two territories. While you are sitting around with a poor attitude, bitching about things you can't control, overlays are getting good bonuses. Whether you welcome them into you territory or not.

Not all overlays are making more, some are making less. It depends on the sum of the territories. They are traveling more, working longer hours, and are constantly unwelcomed. Nothing glam about being an overlay, including bonus.
 




















BG-12 will be submitted in this first half of this year.
FF will have to expand by around 45; still competing with Novartis' larger sales force
BG-12 will have a dedicated FF in first position; it will not be Ty reps
Smaller footprints? not happening

I wouldn't bank on the expansion anytime soon... Biogen just announced that they delayed the FDA filing for BG12 due to some "undisclosed side effects" that need to be investigated... I wonder what these could be?
 








As of now, it looks like 90 Tysabri leads, 90 Avonex leads, 90 BG12 leads. So we are going to expand by 45, hired and trained to hit field by July 1st. Most territories will have 3 reps mirroring each doctor.

And it looks like the current Avonex reps will have BG12 as their secondary product. Yup, you heard me right! Chuck is handing our new product to a group of new reps!!!!

chuckles. is that you chuckles?
 




Fact: No new Biogen rep will ever have bg12 in the primary position
Fact: The overlays are as useless as they come
Fact: I think the overlays are so sub par its amazing
Fact: They will be gone in 24 months once Biogen realizes they are useless

It is not fair to make these statements. I think some people are just p1$$ed because they were hanging their hopes on the new med, and it got the wind out of your sailes just like that. useless? and you wish for the O/L reps to be gone? I bet its your a$$ on the line
 




I wouldn't bank on the expansion anytime soon... Biogen just announced that they delayed the FDA filing for BG12 due to some "undisclosed side effects" that need to be investigated... I wonder what these could be?

It was described in a news article published by BioPharm Insight on Feb 9, 2012 titled

"Biogen evaluating yet to be announced side effects related to BG-12"

as well as one published on Feb 8 titled

"Biogen has not submitted FDA application for BG-12 yet, will not file
for accelerated approval".
 
















hopefully

hopeful? application was submitted last week- do you trolls read????????
The real question is how many more will they hire for this expansion? Will they do more with O/L territories? Contract SFs? Tripping over each other as it is fighting for the same patients, turning into big pharma pod system
 




hopeful? application was submitted last week- do you trolls read????????
The real question is how many more will they hire for this expansion? Will they do more with O/L territories? Contract SFs? Tripping over each other as it is fighting for the same patients, turning into big pharma pod system

STFD...300 ABMs with expansion?WTH?